CanadaFludeoxyglucose (18F) Injection (Brand: BC Cancer; DIN 02433230; Lot FDG20260627A; 0.5 GBq/vial, 24.80 mL, 30.23 GBq total) is affected. A vial was found to be broken at the bottom. Verify if your product is affected, consult your healthcare provider before discontinuing use, contact the recalling firm with questions, and report any side effects or other safety complaints to Health Canada.
What's being recalled
Depth of recall: Healthcare establishments
Companies: BC Cancer, Part of the provincial Health Services Authority, 600 West 10th Avenue, Vancouver, British Columbia V5Z 4E6 Canada.
How to identify it
Brand: BC Cancer, Part of the provincial Health Services Authority; Product Name: Fludeoxyglucose (18F) Injection; Market Authorization: DIN 02433230; Dosage Form: Solution; Strength: Fludeoxyglucose 18F 0.5 GBq/vial; Lot Number: FDG20260627A
The hazard
Fludeoxyglucose (18F) vial containing 24.80 mL (30.23 GBq of the product) used to administered the drug to the patients was found to be broken at the bottom.
What to do
Verify if your product is affected.
Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
Contact the recalling firm if you have any questions about the recall.
Report any health product related side effects to Health Canada.
Report any other health product safety complaints to Health Canada.
The official notice
This page is a summary of the notice published by Health Canada, collected from Health Canada, CFIA and Transport Canada. Check the original before you act on it.
Read the official notice (opens in a new tab)